Examining the effectiveness of general practitioner and nurse promotion of electronic cigarettes versus standard care for smoking reduction and abstinence in hardcore smokers with smoking-related chronic disease: Protocol for a randomised controlled trial

Trials

Volumn 20, Issue 1, 2019, Pages

  Begh, Rachna ^a   Coleman, Tim ^b   Yardley, Lucy ^c,d   Barnes, Rebecca ^e   Naughton, Felix ^f   Gilbert, Hazel ^g   Ferrey, Anne ^a   Madigan, Claire ^a   Williams, Nicola ^a   Hamilton, Louisa ^a   Warren, Yolanda ^a   Grabey, Jenna ^a   Clark, Miranda ^b   Dickinson, Anne ^b   Aveyard, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Addiction; Cessation; Electronic cigarettes; Primary care; Quitting; Smoking; Tobacco; Treatment

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; FEASIBILITY STUDY; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NURSE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PROGRAM ACCEPTABILITY; PROGRAM EFFECTIVENESS; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SMOKING HABIT; SMOKING REDUCTION; ADVERSE EVENT; COMPARATIVE STUDY; ELECTRONIC CIGARETTE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; SMOKING PREVENTION;

CHRONIC DISEASE; ELECTRONIC NICOTINE DELIVERY SYSTEMS; GENERAL PRACTITIONERS; HUMANS; NURSES; OUTCOME ASSESSMENT, HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING PREVENTION; SMOKING REDUCTION;

EID: 85075802981     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-019-3850-1     Document Type: Article

References (69)

1. Office for National Statistics: Adult smoking habits in the UK: 2018. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/adultsmokinghabitsingreatbritain/2018.
2. Action on Smoking and Health: The local costs of tobacco - ASH "Ready Reckoner": 2018 Edition. 2018. Available from: http://ash.lelan.co.uk/.
3. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax. 2002;57(11):967-72.
4. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164(3):358-64.
5. Jiang F, Chen M, Hu C, Bao Y, Jia W. Effects of active and passive smoking on chronic kidney disease in patients with type 2 diabetes mellitus. Zhonghua nei ke za zhi. 2014;53(11):858-64.
6. Muhlhauser I, Bender R, Bott U, Jorgens V, Grusser M, Wagener W, Overmann H, Berger M. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med. 1996;13(6):536-43.
7. Regalado M, Yang S, Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis. 2000;35(4):687-94.
8. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194-200.
9. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, Deykin A, DiMango E, Fish JE, Ford JG, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175(8):783-90.
10. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290(1):86-97.
11. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 2014;348:g1151.
12. Colivicchi F, Mocini D, Tubaro M, Aiello A, Clavario P, Santini M. Effect of smoking relapse on outcome after acute coronary syndromes. Am J Cardiol. 2011;108(6):804-8.
13. Qin R, Chen T, Lou Q, Yu D. Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol. 2013;167(2):342-50.
14. Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H. The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study. J Clin Epidemiol. 2006;59(1):82-9.
15. Farley A, Koshiaris C, Oke J, Ryan R, Szatkowski L, Stevens R, Aveyard P. Physician support of smoking cessation after diagnosis of lung, bladder, or upper aerodigestive tract cancer. Ann Fam Med. 2017;15(5):443-50.
16. Wilson JS, Fitzsimons D, Bradbury I, Stuart Elborn J. Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial. Int J Nurs Stud. 2008;45(4):508-17.
17. Royal College of Physicians, Royal College of Psychiatrists. Smoking and mental health. London: RCP; 2013.
18. Roland M. Linking physicians' pay to the quality of care - a major experiment in the United kingdom. N Engl J Med. 2004;351(14):1448-54.
19. Szatkowski L, Aveyard P. Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision. Br J Gen Pract. 2016;66(642):e10-5.
20. Szatkowski L, McNeill A. The delivery of smoking cessation interventions to primary care patients with mental health problems. Addiction. 2013;108(8):1487-94.
21. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295-303.
22. Jarvis MJ. Why people smoke. BMJ. 2004;328(7434):277-9.
23. Balfour DJ. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. Nicotine Tob Res. 2004;6(6):899-912.
24. Tobacco Advisory Group of The Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP; 2016.
25. West R, Brown J: Smoking toolkit study: monthly tracking of key performance indicators. STS120720. 2019. Available from: http://www.smokinginengland.info/latest-statistics/.
26. West R, Brown J: Electronic cigarettes in England - latest trends. STS140123. 2019. Available from: http://www.smokinginengland.info/latest-statistics/.
27. National Centre for Smoking Cessation Training: E-cigarettes: A briefing for stop smoking service. 2016. Available from https://www.ncsct.co.uk/usr/pub/Electronic_cigarettes._A_briefing_for_stop_smoking_services.pdf.
28. Brown J, West R, Beard E, Michie S, Shahab L, McNeill A. Prevalence and characteristics of e-cigarette users in Great Britain: Findings from a general population survey of smokers. Addict Behav. 2014;39(6):1120-5.
29. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5(2):67-86.
30. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-9.
31. Hajek P, Etter J-F, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109(11):1801-10.
32. Henningfield JE. The tobacco endgame: It's all about behavior. Prev Med. 2014;68(0):11-6.
33. Berg CJ, Barr DB, Stratton E, Escoffery C, Kegler M. Attitudes toward e-cigarettes, reasons for initiating e-cigarette use, and changes in smoking behavior after initiation: A pilot longitudinal study of regular cigarette smokers. Open J Prev Med. 2014;4(10):789-800.
34. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10(2):446-61.
35. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317.
36. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011;11:786.
37. Beard E, Bruguera C, McNeill A, Brown J, West R. Association of amount and duration of NRT use in smokers with cigarette consumption and motivation to stop smoking: A national survey of smokers in England. Addict Behav. 2015;40(0):33-8.
38. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.
39. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;9:Cd010216.
40. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, Li J, Parrott S, Sasieni P, Dawkins L, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629-37.
41. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health. 2014;11(11):11220-48.
42. Biener L, Lee Hargraves J. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: Association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127-33.
43. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109(9):1531-40.
44. Grana R, Benowitz N, Glantz SA. E-cigarettes: A scientific review. Circulation. 2014;129(19):1972-86.
45. McNeill A, Brose L, Calder R, Bauld L, Robson D. Evidence review of e-cigarettes and heated tobacco products 2018: a report commissioned by Public Health England. London: Public Health England. London: Public Health England; 2018.
46. NICE: Stop smoking interventions and services [NG92]. 2018. Available from: https://www.nice.org.uk/guidance/ng92/chapter/Recommendations.
47. Steinberg MB, Giovenco DP, Delnevo CD. Patient-physician communication regarding electronic cigarettes. Prev Med Rep. 2015;2(0):96-8.
48. Stepney M, Aveyard P, Begh R. GPs' and nurses' perceptions of electronic cigarettes in England: a qualitative interview study. Br J Gen Pract. 2019;69(678):e8-e14.
49. Crossfield AW, T. Identifying and measuring the views, beliefs, experiences, concerns and attitudes of stop smoking practitioners in relation to e-cigarettes: How can we support stop smoking practitioners to apply their knowledge and understanding of e-cigarettes Conference presentation at UK National Smoking Cesssation Conference, Manchester; 2015. Available at: http://www.uknscc.org/uknscc2015_presentation_408.php?show=bio.
50. McNeill A, Brose L, Calder R, Hitchman S, Hajek P, McRobbie H. E-cigarettes: An evidence update. A report commissioned by Public Health England. London: Public Health England; 2015.
51. Aveyard P, Begh R, Parsons A, West R. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012;107(6):1066-73.
52. Vidrine J, Shete S, Cao Y, et al. Ask-advise-connect: A new approach to smoking treatment delivery in health care settings. JAMA Intern Med. 2013;173(6):458-64.
53. Lewis A, Jolly K, Adab P, Daley A, Farley A, Jebb S, Lycett D, Clarke S, Christian A, Jin J, et al. A brief intervention for weight management in primary care: study protocol for a randomized controlled trial. Trials. 2013;14:393.
54. Bandura A, Walters RH. Social learning theory, vol. 1. Englewood Cliffs: Prentice-hall; 1977.
55. DiMatteo MR, Robinson JD, Heritage J, Tabbarah M, Fox SA. Correspondence among patients' self-reports, chart records, and audio/videotapes of medical visits. Health Commun. 2003;15(4):393-413.
56. Pringle M, Stewart-Evans C. Does awareness of being video recorded affect doctors' consultation behaviour? Br J Gen Pract. 1990;40(340):455-8.
57. Williams S, Yardley L, Weal MJ, Wills G. Introduction to LifeGuide: Open-source software for creating online interventions for health care, health promotion and training. In: Medetel: Global Telemedicine and eHealth Updates. Zürich: International Society for Telemedicine & eHealth; 2010. p. 187-90.
58. Michie S, Wood CE, Johnston M, Abraham C, Francis JJ, Hardeman W. Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data). Health Technology Assess. 2015;19(99):1-188.
59. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65-70.
60. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299-303.
61. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess B, editors. Analysing qualitative data. London: Routledge; 1994. p. 173-94.
62. Sidnell J, Stivers T. The handbook of conversation analysis. Oxford: Wiley-Blackwell; 2013.
63. Barnes RK. Making sense of qualitative research: Conversation analysis: a practical resource in the healthcare setting. Med Educ. 2005;39:113-5.
64. Barnes RK, Jepson M, Thomas C, Jackson S, Metcalfe C, Kessler D, Cramer H. Using conversation analytic methods to assess fidelity to a talk-based healthcare intervention for frequently attending patients. Soc Sci Med (1982). 2018;206:38-50.
65. Robinson JD, Heritage J. How patients understand physicians' solicitations of additional concerns: implications for up-front agenda setting in primary care. Health Commun. 2016;31(4):434-44.
66. Robinson JD, Heritage J. Intervening with conversation analysis: The case of medicine. Res Lang Soc Interact. 2014;47(3):201-18.
67. Perez-Stable EJ, Benowitz NL, Marin G. Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med. 1995;24(2):171-9.
68. Foulds J, Bryant A, Stapleton J, Jarvis MJ, Russell MA. The stability of cotinine in unfrozen saliva mailed to the laboratory. Am J Public Health. 1994;84(7):1182-3.
69. Jacob P 3rd, Yu L, Shulgin AT, Benowitz NL. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health. 1999;89(5):731-6.